BioMed Realty (“Company”), the largest privately owned operator of real estate for the life science and technology industries in the United States and the United Kingdom, today released its 2024 Sustainability Report, demonstrating continued industry leadership in sustainable development, decarbonization, community partnership, and responsible business operations. The report showcases how BioMed Realty’s tenant-first and vertically integrated model consistently provide dependable, high-performing spaces that fuel innovation and create long-term value for tenants, stakeholders, and communities.

This year’s report is complemented by BioMed Realty’s strong performance in the 2025 Global Real Estate Sustainability Benchmark (GRESB). BioMed Realty is a portfolio company within Blackstone’s Core+ Life Sciences Real Estate strategy, which achieved 4-Star ratings in both Standing Assets and Development Assets, improving its scores again in both categories year-over-year. The Company also earned a first-place ranking in the Development Benchmark within the Technology/Science/Non-listed/Core category in the Americas for the second consecutive year, reinforcing its leadership in creating sustainable, future-ready innovation spaces.

“Our sustainability strategy is grounded in our role as a long-term partner to the world’s most innovative companies,” said Tim Schoen, CEO of BioMed Realty. “This year’s report highlights how our vertically integrated model continues to perform. Our seamless approach from development through operations creates the flexible, mission-critical environments tenants rely on to accelerate innovation, while supporting the long-term viability of our operating portfolio. Our momentum and top-tier GRESB scores demonstrate both the rigor of our strategy and the consistency of our execution over more than 20 years.”

The 2024 Sustainability Report outlines BioMed Realty’s continued progress embedding sustainable design, resilience, and occupant well-being across its development and operational lifecycle. Across the U.S., all new ground-up developments target designs which achieve LEED® Silver or higher, incorporate solar-ready infrastructure, and make meaningful reductions in energy and water consumption aligned with rigorous ASHRAE baselines. These environments are purpose-built to support tenant health, foster collaboration, and enhance productivity; ultimately providing value and efficiency for tenants which make BioMed Realty a preferred landlord of choice for the world’s leading innovative companies. In the U.K., new developments are held to similarly ambitious performance standards, targeting BREEAM Excellent, EPC A ratings, and at least a 25% reduction in operational carbon emissions relative to a BREEAM notional building baseline compliance with applicable UK Building Regulations Part L2B requirements.

The report also highlights BioMed Realty’s progress to advance long-term energy efficiency and sustainability across its 17-million-square-foot global operating portfolio. This year, the Company procured renewable energy credits (RECs) representing 100% of landlord-paid electricity across the U.S. and progressed a multi-year energy optimization strategy focused on equipment end-of-life upgrades and major retrofit opportunities. Since 2016, BioMed Realty has completed 192 energy-efficiency projects, representing over $25 million in investment and generating more than $4.5 million in cumulative energy savings. This improvement in performance has contributed to rising scores in the GRESB Standing Assets category.

"BioMed Realty’s year-over-year results demonstrate meaningful sustainability progress,” said Joanna Hilvert, Vice President, Environmental, Sustainability and Integration. “Our tenant-first ethos guides the decisions we make, and these results demonstrate how that focus—paired with our integrated model—delivers resilient, sustainable environments that keep discovery and innovation moving and strengthen long-term performance.”

Consistent with Blackstone Real Estate’s long-term investment approach, BioMed Realty continues to prioritize healthy, inclusive, and vibrant spaces that support tenant success, satisfaction, and strengthen local communities. Highlights from this year’s report include:

• 17 Fitwel-certified properties and additional certifications are underway. Developments such as Granta Park in Cambridge, U.K., and the Center for Novel Therapeutics in San Diego showcase the integration of wellness-focused design, advanced amenities, rainwater reuse systems, and on-site solar generation.
• BioMed’s Discover Here program further enhanced tenant engagement, hosting more than 570 events across markets that included networking gatherings, wellness clinics, sustainability initiatives, and community-building activities.
• BioMed supported more than 80 nonprofit organizations, deepening its role as an active community partner.

To learn more about BioMed Realty’s sustainability efforts, visit the Company’s newly redesigned website at www.biomedrealty.com/stewardship/planet.

About BioMed Realty

BioMed Realty is the largest privately owned operator of real estate for the life science and technology industries in the United States and United Kingdom. The Company operates 17.3 million square feet of purpose-built laboratory and office space across the world’s top innovation hubs, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder, and Cambridge, U.K. With an additional 1.5 million square feet of Class A properties under development, BioMed Realty delivers flexible, reliable, and sustainable environments designed to accelerate discovery and keep world-changing work moving. Backed by more than 20 years of experience and the strength of being a Blackstone Real Estate portfolio company, BioMed Realty provides the confidence and partnership that fuel life-enhancing and world-changing innovation. To learn more, visit www.biomedrealty.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251223606639/en/